Leading ITP clinicians come together and deliver consensus guidelines for the treatment of (ITP) in adult patients.
Leading ITP clinicians come together and deliver consensus guidelines for the treatment of (ITP) in adult patients.
From Monday, 25th September to Saturday, 30th September, Australia and New Zealand turned PURPLE for Immune Thrombocytopenia in the annual #LightUp4ITP awareness campaign, and we kicked off the inaugural #Planking4Platelets challenge.
Spotlight on the ITP International Alliance – PTI Brasil and Marilia Lia
MEET – CONNECT – SHARE – Join us online during our regular Virtual Patient Meetings.
Danielle and Patricia from ITP Australia had the wonderful experience of attending the UK ITP Support Association’s Patient Convention on Saturday, 13 May 2023.
Spending time taking care of yourself is not selfish. It’s critical to good health.
Earlier this year, Thrombopoietin Receptor Agonists, including NPlate and Revolade, became easier to access for ITP patients with the restrictions being removed. This was a big win for ITP Patients in Australia, which has improved the Quality of Life for many since this change.
Well, the changes don’t stop there!
Welcome to the latest ITP Australia – The Count Winter 2023 Edition.
Our quarterly newsletter includes information on the latest updates and activities by ITP Australia and in the world of Immune Thrombocytopenia.
The current contract arrangements for the supply of imported immunoglobulin products commenced on 1 January 2021. Those arrangements included provisions for some additional products to be added as they became available. The National Blood Authority is now pleased to announce that a new imported intravenous immunoglobulin (IVIg) product, Kiovig 10% (Takeda), will be available to order from Lifeblood from 1 May 2023.